Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies
暂无分享,去创建一个
A. Noè | B. Holzhauer | T. Thuren | A. Skerjanec | C. Howard | M. Ligueros‐Saylan | M. Wernsing | Adele Noè